Latest Panton-Valentine leukocidin Stories
Transparency Market Research Report Added "Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018"
A good disguise enables the nanosponge to soak up toxins from drug-resistant infections or poisons
In analysis that included more than 9 million Department of Defense nonactive and active duty personnel, the rates of both community-onset and hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia decreased from 2005 to 2010, while the proportion of community-onset skin and soft tissue infections due to MRSA has more recently declined, according to a study in the July 4 issue of JAMA.
New study identifies, quantifies and characterizes its prevalence.
With the H1N1 â€œswine fluâ€ still spreading around the world, people are understandably concerned not only about the disease itself, but about the future implications.
USA300â€”the major epidemic strain of methicillin-resistant Staphylococcus aureus (MRSA) causing severe infections in the United States during the past decadeâ€”inherits its destructiveness directly from a forefather strain of the bacterium called USA500 rather than randomly acquiring harmful genes from other MRSA strains.
Researchers at The University of Texas School of Public Health recently described studies that support the link between the severity of community-acquired antibiotic-resistant Staphylococcus aureus (CA MRSA) infections and the Panton Valentine leukocidin (PVL).The Panton Valentine leukocidin is made up of two components - LukF-PV and LukS-PV - and is typically produced by community-acquired methicillin-resistant S. aureus (CA MRSA). In the United States this strain is the most common CA MRSA...
Nabi Biopharmaceuticals has announced that the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has entered into collaboration with Nabi to advance the company's PentaStaph vaccine candidate for the prevention and treatment of Staphylococcus aureus infections in the community and hospital settings.
ROCKVILLE, Md., Sept.
By N, Jung C, Lehmann; M, Hellmann; H, Seifert; M, Valter M; M, Hallek; G, Fatkenheuer; M, Kochanek Abstract BACKGROUND: Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus is emerging as a serious problem worldwide.